Furthermore in population studies on necropsy, it has repeatedly been shown that of deaths certified as due to congenital heart disease, about two-thirds were within the first year of life and about half of these were during the first month.3 Population necropsy studies tend to present a gloomier prognosis than those based on diagnosis in life as well death. Nevertheless, in a study of the latter type carried out as recently as , it was shown that, even when patients with severe associated congenital lesions were excluded, only 61 % of infants with congenital heart disease survived the first year.4 Effective prevention of congenital heart disease seems unlikely to emerge within the next decade, so that any policy designed to reduce death and disability from congenital heart disease must at present be focused on management during the early months of life. The paper by Izukawa et al.5 (page 281) documents in a heartening manner the improvement in life expectancy that has occurred in newborns with structural heart disease in the last decade treated at their hospital, which acts as a referral centre for a large part of Canada.
In a number of committee reports on resources for management ofheart disease in children, the principle has been accepted that in order to provide optimal standards of care, a limited number of specialist centres are required.6'7'8 9 A revised report of the Joint Cardiology Committee is about to be published, taking the same view. This annotation will summarise the evidence supporting this view, and argue that in order to provide the best service for newborn babies with congenital heart disease, it is necessary to think in terms of creation of supraregional centres specialising in the care not just of newborns, but also of infants.
The . One large centre reported a further 54, too late for inclusion, but it is difficult to believe that the overall total from every centre in England and Wales could exceed 500 per annum. This leaves the total figure still 190 This figure for the number of supraregional centres required is uncomfortably low, and specialisation of this order would undoubtedly introduce new problems. What are they, and would they outweigh the benefits ? The first disadvantage is of course that there would be a lot of travelling for the baby and relatives. This will never be a pleasant experience, but then neither is the unnecessary death of the baby. We (and doubtless others) have found that it is possible for a young infant to suffer several cardiac arrests outside the UK, and yet to survive a long air flight and corrective surgery in this country. This illustrates graphically that transport need not be hazardous provided that the means to maintain thermal, fluid, and acid-base balance, together with ventilation (if necessary), are initiated before the journey.
At the moment, such care is undertaken by the referring nonspecialist hospital. In the future, the responsibility for this kind of action may come to rest with the specialist centres, along the lines developed by general neonatal intensive care units.16'17 But because of the far greater distances, this would place demands upon the medical and nursing personnel in the specialist centres that would be extremely heavy, and certainly beyond the present capabilities of any unit of this type in the country.
Of particular concern, as so many of these emergencies occur in the first few days of life, is that the baby may be transported, but the mother is not. This inevitably impairs primary bonding and establishment of breast feeding. This is perhaps particularly unfortunate if the physical condition of the baby turns out not to be serious. These problems would, in my view, be greatly alleviated by a 2-pronged strategy. Firstly, paediatric cardiologists would have to take more seriously their educational role with regard to budding (or even not so budding) paediatricians and neonatologists, as these play such a vital role in screening for serious structural heart disease. This would not only reduce unnecessary referrals (which are in any case rare), but, more importantly, help to ensure earlier referral of serious heart disease before the baby's condition becomes critical. Secondly, mothers could be encouraged more often to accompany their babies (particularly if they have no other children) and would be actively helped to do so, even if it meant extra medical care for the mother.
Cardiac catheterisation and surgery are not cheap when viewed in isolation, but there can hardly be another specialty where such sick individuals are so completely restored to normality for such a long time. So the cost-benefit ratio, insofar as this can be quantified, is probably low compared with many other widely performed procedures. All in all, the benefits of supraregionalisation of infant cardiac care far outweigh the disadvantages, provided that the latter are minimised along the lines suggested.
It is true that in 1979, now that some lesions can be repaired in infancy with an immediate survival of better than 95 % in a few centres, that the residual problems are becoming more and more concentrated in the first month of life.18 But for three reasons, my view is that it would be a mistake at this stage to create neonatal rather than infant supraregional centres. Firstly, the number would be too small. Secondly, open heart surgery in later infancy is still far from routine even in specialist centres. Thirdly, some of the numerically most important conditions causing serious cardiac disability and death in infancy do not normally present until the 2nd and 3rd month of life, notably ventricular septal defect. Since it has been clearly shown that in certain centres, primary closure of the defect in infants with intractable cardiac failure carries a lower early and late mortality than banding of the pulmonary artery,'9'20 there seems to be a good argument for the creation of centres where such open heart approaches to treatment may become routine. At this time, only a few such hospitals in this country have established reputations in the field, so that recognising these as supraregional centres would not be difficult. The longer action along these lines is delayed, the more centres will become involved. Rationalisation could then become painful to the point at which it would never happen. The arguments put forward will perhaps have convinced even the sceptical that this would be a pity.
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